- Home >
- Publications >
- Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies
Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies
Authors
Pavel Mozgunov, Thomas Jaki, Xavier Paoletti
Teams
